Tag Archives: disease progression

Yunzhi Slows Progression of Advanced Non-small Cell Lung Cancer

Posted on February 6, 2011 by wngai

Non-small cell lung cancer (NSCLC) is a leading cause of cancer deaths, but most patients (over 69%) were diagnosed at advanced stages.  Although polysaccharide peptides (PSP), isolated from the fungus Yunzhi (Coriolus versicolor), have been reported to have anti-tumor effects … Continue reading →

Posted in Alternative Medicine, Cancer, Non Small Cell Lung Cancer | Tagged , , , , , , , , , , | Comments Off on Yunzhi Slows Progression of Advanced Non-small Cell Lung Cancer

FDA Panel Supports the Use of Vandetanib in Medullary Thyroid Cancer

Posted on December 22, 2010 by wngai

An FDA advisory committee reported that they supported the use of AstraZeneca’s vandetanib for the treatment of patients with medullary thyroid cancer (MTC).   However, they also indicated the drug should be reserved for patients who are experiencing symptoms of their … Continue reading →

Posted in Cancer, Thyroid Cancer | Tagged , , | Comments Off on FDA Panel Supports the Use of Vandetanib in Medullary Thyroid Cancer

Cetuximab (Erbitux) Reduces Disease Progression in Triple Negative Breast Cancer

Posted on October 16, 2010 by wngai

Patients with triple negative breast cancer usually have poor prognosis, but a new drug might soon be available to improve the survival in these patients.   Mid-stage study results presented at the European Society for Medical Oncology congress indicated that cetuximab(Erbitux) … Continue reading →

Posted in Breast cancer, Cancer | Tagged , , , , , | Comments Off on Cetuximab (Erbitux) Reduces Disease Progression in Triple Negative Breast Cancer